← Back to Search

Calcium Supplement

Bisphosphonates/Non-Micronized Calcium Carbonate/Vitamin D3 for Osteoporosis

N/A
Waitlist Available
Led By Gilbert R Kaats, PhD FACN
Research Sponsored by Integrative Health Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 183 days
Awards & highlights

Study Summary

The purpose of this study is to determine whether consuming calcium carbonate that has been micronized is more effective than the traditional form of calcium carbonate in maintaining or increasing bone mineral density in people who are currently taking bisphosphonates or other bone-health medications.

Eligible Conditions
  • Osteoporosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 and 183 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 and 183 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Absorptiometry, X-Ray
Secondary outcome measures
Blood Chemistry Panel
Number of participants with adverse effects
Resting heart rate
+2 more

Trial Design

4Treatment groups
Active Control
Group I: Bisphosphonates/Non-Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total amount of 1000 mg of Non-Micronized Calcium Carbonate and 800 IU Vitamin D3.
Group II: Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects who are not currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total of 500 mg of Micronized Calcium Carbonate and 800 IU Vitamin D3
Group III: Non-Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects who are not currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total of 1000 mg of Non-Micronized Calcium Carbonate and 800 IU Vitamin D3.
Group IV: Bisphosphonates/Micronized Calcium Carbonate/Vitamin D3Active Control2 Interventions
Subjects currently being treated with Bisphosphonates will replace any calcium they are currently taking with four Capsules/Day containing a total amount of 500 mg of Micronized Calcium Carbonate and 800 IU Vitamin D3

Find a Location

Who is running the clinical trial?

Integrative Health Technologies, Inc.Lead Sponsor
5 Previous Clinical Trials
849 Total Patients Enrolled
Gilbert R Kaats, PhD FACNPrincipal InvestigatorIntegrative Health Technologies, Inc.
3 Previous Clinical Trials
425 Total Patients Enrolled
Harry G Preuss, MD MACNStudy ChairGeorgetown University Medical Center, Dept of Biochemistry, Medicine and Pathology
3 Previous Clinical Trials
425 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study of Changes in Bone Mineral Density as a Function of Consuming Two Different Forms of Calcium Carbonate
Gilbert R Kaats 2013. "A Study of Changes in Bone Mineral Density as a Function of Consuming Two Different Forms of Calcium Carbonate". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01857154.
All > Vitamin D
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top